Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004011

Options or other derivatives

  • Chief Financial Officer acquired 79,525 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick Chief Financial Officer 2020-03-17 Grant or award · Employee Stock Option (Right to Buy) +60,880 60,880 D
Pizzie Nick Chief Financial Officer 2020-03-17 Grant or award · Restricted Stock Units +18,645 18,645 D
Loading xslF345X03/edgar.xml…